Page last updated: 2024-08-23

etoposide and Chromosome Deletion

etoposide has been researched along with Chromosome Deletion in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (6.67)	18.7374
1990's	6 (40.00)	18.2507
2000's	5 (33.33)	29.6817
2010's	2 (13.33)	24.3611
2020's	1 (6.67)	2.80

Authors

Authors	Studies
Abe, K; Dowsett, L; Hutchins, K; Wada, R	1
Agama, K; Brünner, N; Doroshow, JH; Jensen, NF; Knudsen, BR; Pfister, TD; Pommier, Y; Roy, A; Rømer, MU; Smith, DH; Stenvang, J; Zhang, HL	1
Creutzig, U; Reinhardt, D; Sander, A; Von Neuhoff, C	1
Couturier, J; de Cremoux, P; Delattre, O; Doz, F; Fehlbaum, P; Jourdan-Da-Silva, N; Klijanienko, J; Michon, J; Mosseri, V; Schleiermacher, G; Tran-Perennou, C; Vielh, P	1
Brichard, B; Chantrain, C; De Potter, P; Gala, JL; Sibille, C; Vermylen, C	1
Fujita, H; Kurata, M; Maeda, A; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Takahashi, T; Tanaka, K; Tanaka, Y; Togami, K	1
Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ	1
Hirakawa, K; Horiike, S; Kaneko, H; Kashima, K; Misawa, S; Nakai, H; Nakao, M; Taniwaki, M; Ueda, Y	1
Grander, D; Heyman, M; Jeddi-Tehrani, M; Johansson, B; Liu, Y; Nordgren, A; Ost, A; Rasool, O; Wallberg, B	1
Fuscoe, JC; Hanley, NM; Knapp, GW; Pui, CH; Relling, MV; Sandlund, JT; Setzer, RW	1
Bernasconi, P; Boni, M; Castoldi, GL; Ciolli, S; Clavio, M; Cox, MC; Cuneo, A; Del Poeta, G; Dini, D; Falzetti, D; Fanin, R; Gobbi, M; Isidori, A; Leoni, F; Liso, V; Malagola, M; Mandelli, F; Martinelli, G; Mecucci, C; Petti, MC; Piccaluga, PP; Rondelli, R; Russo, D; Sessarego, M; Specchia, G; Testoni, N; Torelli, G; Tura, S; Visani, G	1
Home, R; Hooker, AM; Horne, R; Morley, AA; Sykes, PJ	1
Berger, NA; Chatterjee, S; Helms, SR; Schmotzer, JA	1
Granada, I; Las Heras, G; Millá, F; Ribera, JM	1
Bénard, J; Da Silva, J; Riou, G; Teyssier, JR	1

Reviews

1 review(s) available for etoposide and Chromosome Deletion

Article	Year
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients. Leukemia, 2001, Volume: 15, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Deletion; Chromosome Inversion; Chromosomes, Human; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hepatomegaly; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Retrospective Studies; Splenomegaly; Survival Analysis; Translocation, Genetic; Treatment Outcome	2001

Article

Year

The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.

Leukemia, 2001, Volume: 15, Issue:6

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Deletion; Chromosome Inversion; Chromosomes, Human; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hepatomegaly; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Retrospective Studies; Splenomegaly; Survival Analysis; Translocation, Genetic; Treatment Outcome

2001

Other Studies

14 other study(ies) available for etoposide and Chromosome Deletion

Article	Year
A pediatric case of acute myeloid leukemia with KMT2A gene rearrangement t(10;11) and 16p11.2 microdeletion syndrome. Pediatric blood & cancer, 2021, Volume: 68, Issue:2 Topics: Antineoplastic Agents; Autistic Disorder; Child; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 16; Cytarabine; Daunorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histone-Lysine N-Methyltransferase; Humans; Intellectual Disability; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 3; Myeloid-Lymphoid Leukemia Protein; Vault Ribonucleoprotein Particles	2021
Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations. Journal of experimental & clinical cancer research : CR, 2016, Mar-31, Volume: 35 Topics: Benzodioxoles; Binding Sites; Camptothecin; Cell Line, Tumor; Chromosome Deletion; Colonic Neoplasms; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Gene Dosage; Guanidines; HCT116 Cells; HT29 Cells; Humans; Hydrazones; Irinotecan; Isoquinolines; Mutation	2016
[Genetic prognostic factors in childhood acute myeloid leukemia]. Klinische Padiatrie, 2012, Volume: 224, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 7; Cytarabine; DNA Mutational Analysis; Etoposide; Female; fms-Like Tyrosine Kinase 3; Genes, Wilms Tumor; Genetic Markers; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Karyotyping; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Nuclear Proteins; Nucleophosmin; Prognosis; Survival Rate; Translocation, Genetic	2012
Role of chemotherapy resistance genes in outcome of neuroblastoma. Pediatric blood & cancer, 2007, Volume: 48, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Cell Line, Tumor; Child; Child, Preschool; Chromosome Deletion; Chromosomes, Human, Pair 1; Cisplatin; Computer Systems; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Profiling; Genes, MDR; Genes, myc; Humans; Infant; Kaplan-Meier Estimate; Male; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; S Phase; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine	2007
Retinoblastoma and deletion of the long arm of chromosome 13: an underestimated diagnosis? Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Deletion; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 8; Combined Modality Therapy; Etoposide; Eye Enucleation; False Negative Reactions; Female; Genes, Retinoblastoma; Humans; Hyperthermia, Induced; In Situ Hybridization, Fluorescence; Infant; Neoplasms, Multiple Primary; Remission Induction; Retinal Neoplasms; Retinoblastoma; Skull; Translocation, Genetic; Vincristine	2008
Multiple granulocytic sarcomas in essential thrombocythemia. International journal of hematology, 2006, Volume: 84, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Chromosome Deletion; Chromosomes, Human, Pair 7; Cytarabine; Etoposide; Fatal Outcome; Female; Femoral Fractures; Femoral Neoplasms; Humans; Hydroxyurea; Middle Aged; Mitobronitol; Neoplasm Metastasis; Nitrosourea Compounds; Primary Myelofibrosis; Radiography; Sarcoma, Myeloid; Thrombocythemia, Essential	2006
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood, 1995, Jun-01, Volume: 85, Issue:11 Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation	1995
Double mutations of the N-ras gene in a patient with acute myelomonocytic leukemia. International journal of hematology, 1995, Volume: 61, Issue:4 Topics: Aclarubicin; Alleles; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 9; Codon; Cytarabine; Daunorubicin; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Genes, ras; Genetic Vectors; Humans; Karyotyping; Leukemia, Myelomonocytic, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Point Mutation; Prednisolone; Vinblastine; Vincristine	1995
A T cell lymphoblastic lymphoma patient with two malignant cell populations carrying different 9p deletions including the p16INK4 and p15INK4B genes: Clinical response to interferon-alpha therapy in one of the subclones. Leukemia, 1996, Volume: 10, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Cycle Proteins; Chromosome Deletion; Chromosomes, Human, Pair 9; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Gene Deletion; Humans; Immunologic Factors; Interferon-alpha; Male; Neoplasm Proteins; Neoplastic Stem Cells; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; RNA, Messenger; RNA, Neoplasm; Salvage Therapy; Tumor Suppressor Proteins; Vincristine	1996
The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy. Mutation research, 1998, Nov-09, Volume: 419, Issue:1-3 Topics: Base Sequence; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; DNA Nucleotidyltransferases; Etoposide; Humans; Lymphocytes; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic; VDJ Recombinases	1998
Dose-dependent increase or decrease of somatic intrachromosomal recombination produced by etoposide. Mutation research, 2002, Mar-20, Volume: 500, Issue:1-2 Topics: Animals; beta-Galactosidase; Cell Division; Cell Line; Chromosome Deletion; Chromosome Inversion; Chromosomes; Dose-Response Relationship, Drug; Escherichia coli; Etoposide; Hybridomas; Mice; Mice, Transgenic; Mutagens; Recombination, Genetic	2002
Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death. Proceedings of the National Academy of Sciences of the United States of America, 1991, Oct-01, Volume: 88, Issue:19 Topics: Animals; Cell Line; Cell Survival; Chromosome Deletion; Cricetinae; Cricetulus; DNA Damage; DNA Mutational Analysis; Etoposide; Hypoxanthine Phosphoribosyltransferase; Polymorphism, Restriction Fragment Length	1991
[Acute myeloblastic leukemia 5q-. Clinical and cytogenetic remission by means of intensive chemotherapy]. Sangre, 1991, Volume: 36, Issue:3 Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 5; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Megakaryoblastic, Acute; Male; Middle Aged; Mitoxantrone; Mosaicism; Remission Induction	1991
Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line. International journal of cancer, 1989, Mar-15, Volume: 43, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chromosome Deletion; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Phenotype; Tumor Cells, Cultured; Verapamil; Vincristine	1989